4.7 Review

Chitosan as an Underrated Polymer in Modern Tissue Engineering

期刊

NANOMATERIALS
卷 11, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/nano11113019

关键词

chitosan; biopolymer; biomedicine; bioprinting; 3D; bio-ink

资金

  1. TECHMATSTRATEG [III/0027/2019-00]

向作者/读者索取更多资源

Chitosan, with its unique chemical, biological, and physical properties, is extensively used in tissue engineering as a main component in biomaterials. It can be modified and blended to meet specific requirements, making it versatile for various applications such as membranes, scaffolds, drug carriers, and hydrogels.
Chitosan is one of the most well-known and characterized materials applied in tissue engineering. Due to its unique chemical, biological and physical properties chitosan is frequently used as the main component in a variety of biomaterials such as membranes, scaffolds, drug carriers, hydrogels and, lastly, as a component of bio-ink dedicated to medical applications. Chitosan's chemical structure and presence of active chemical groups allow for modification for tailoring material to meet specific requirements according to intended use such as adequate endurance, mechanical properties or biodegradability time. Chitosan can be blended with natural (gelatin, hyaluronic acid, collagen, silk, alginate, agarose, starch, cellulose, carbon nanotubes, natural rubber latex, kappa-carrageenan) and synthetic (PVA, PEO, PVP, PNIPPAm PCL, PLA, PLLA, PAA) polymers as well as with other promising materials such as aloe vera, silica, MMt and many more. Chitosan has several derivates: carboxymethylated, acylated, quaternary ammonium, thiolated, and grafted chitosan. Its versatility and comprehensiveness are confirming by further chitosan utilization as a leading constituent of innovative bio-inks applied for tissue engineering. This review examines all the aspects described above, as well as is focusing on a novel application of chitosan and its modifications, including the 3D bioprinting technique which shows great potential among other techniques applied to biomaterials fabrication.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Immunology

Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes

Paulina Niedzwiedzka-Rystwej, Mikolaj Wolacewicz, Piotr Cywoniuk, Marta Klak, Michal Wszola

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2020)

Article Multidisciplinary Sciences

Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets

M. Klak, M. Gomolka, T. Dobrzanski, G. Tymicki, P. Cywoniuk, P. Kowalska, K. Kosowska, T. Bryniarski, A. Berman, A. Dobrzyn, J. Idaszek, W. swieszkowski, M. Wszola

PLOS ONE (2020)

Review Chemistry, Analytical

Novel Strategies in Artificial Organ Development: What Is the Future of Medicine?

Marta Klak, Tomasz Bryniarski, Patrycja Kowalska, Magdalena Gomolka, Grzegorz Tymicki, Katarzyna Kosowska, Piotr Cywoniuk, Tomasz Dobrzanski, Pawel Turowski, Michal Wszola

MICROMACHINES (2020)

Article Chemistry, Analytical

Bionic Organs: Shear Forces Reduce Pancreatic Islet and Mammalian Cell Viability during the Process of 3D Bioprinting

Marta Klak, Patrycja Kowalska, Tomasz Dobrzanski, Grzegorz Tymicki, Piotr Cywoniuk, Magdalena Gomolka, Katarzyna Kosowska, Tomasz Bryniarski, Andrzej Berman, Agnieszka Dobrzyn, Wojciech Sadowski, Bartosz Gorecki, Michal Wszola

Summary: This study assessed the impact of 3D bioprinting process on islet viability, showing that optimal pressure for printing pancreatic islets should be lower than 30 kPa when using 3% alginate as a carrier. This finding highlights the importance of pressure control in achieving high viability of islets during 3D bioprinting.

MICROMACHINES (2021)

Article Biochemistry & Molecular Biology

Impact of Porcine Pancreas Decellularization Conditions on the Quality of Obtained dECM

Marta Klak, Ilona Lojszczyk, Andrzej Berman, Grzegorz Tymicki, Anna Adamiok-Ostrowska, Maciej Sierakowski, Radoslaw Olkowski, Andrzej Antoni Szczepankiewicz, Artur Kaminski, Agnieszka Dobrzyn, Michal Wszola

Summary: This study aimed to assess the safety of decellularized porcine pancreas and analyze the risk of an undesirable immune response. Through testing different variants of the decellularization process, the most favorable variant in terms of quality and biology was chosen, demonstrating an effective and safe method for the development of transplant and regenerative medicine.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Cell Biology

Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes

Michal Wszola, Daria Nitarska, Piotr Cywoniuk, Magdalena Gomolka, Marta Klak

Summary: Type 1 diabetes is a common autoimmune disease that can be treated by culturing human stem cells to differentiate into insulin and glucagon-producing cells for the creation of a bionic pancreas. Solutions for post-transplant immune responses triggered by stem cell-derived pancreatic cells need further exploration.
Article Biochemistry & Molecular Biology

Streptozotocin-Induced Diabetes in a Mouse Model (BALB/c) Is Not an Effective Model for Research on Transplantation Procedures in the Treatment of Type 1 Diabetes

Michal Wszola, Marta Klak, Anna Kosowska, Grzegorz Tymicki, Andrzej Berman, Anna Adamiok-Ostrowska, Joanna Olkowska-Truchanowicz, Izabela Uhrynowska-Tyszkiewicz, Artur Kaminski

Summary: The study investigated the use of streptozotocin (STZ) to induce diabetes in mice, leading to over 90% destruction of beta-cell mass. However, STZ doses below 300 mg/kg did not show significant changes in islet area and insulin-positive areas in mice.

BIOMEDICINES (2021)

Review Immunology

Type 1 diabetes: genes associated with disease development

Marta Klak, Magdalena Gomolka, Patrycja Kowalska, Justyna Cichon, Filip Ambrozkiewicz, Marta Serwanska-Swietek, Andrzej Berman, Michal Wszola

CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

暂无数据